<DOC>
	<DOCNO>NCT01588132</DOCNO>
	<brief_summary>In 94 healthy subject Phase I clinical trial , assess clinical profile Anfibatide , specific glycoprotein Ib antagonist . This study represent first clinical evidence Anfibatide exhibit strong anti-platelet effect , excellent reversibility , low bleed potential healthy human subject .</brief_summary>
	<brief_title>Anfibatide Phase 1 Clinical Trial Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>1 ) Healthy volunteer , age 1828 year , male female include , age difference less 10 year ; 2 ) Body weight : body mass index ( BMI ) 1924 , difference le 10kg group , BMI=body weight ( kg ) /height2 ; 3 ) Past medical history : history heart , liver , kidney , digestive tract , nervous system metabolic disorder , ulcer , significant hemorrhage , without history drug allergy postural hypotension ; 4 ) Medical examination : normal result overall examination ( include heart rate , blood pressure , auscultation heart lung , palpation liver spleen , hepatic renal function , hematology , coagulation function , urine analysis , stool analysis occult blood test , electrocardiogram ) ; 5 ) Have receive medication within 2 week study ; 6 ) Willing participate study give sign informed consent form understand study procedure potential adverse reaction study product . 1 ) History HBV HCV infection ; 2 ) Addicted smoke alcohol ; 3 ) Women pregnancy , lactation menstrual period ; 4 ) Past history hemoptysis , bloody stool , bleed spot skin mucous membrane , hemorrhagic tendency ( find prone bleeding gum , nose , skin mucous membrane , hemoptysis ) ; 5 ) History active bleeding ( peptic ulcer , hemorrhoid , active tuberculosis , subacute bacterial endocarditis , etc ) ; 6 ) Blood platelet count le 150Ã—109 ; 7 ) Trauma history ( e.g. , craniocerebral trauma ) recently ; 8 ) Past history unexplained syncope convulsion ; 9 ) History organic psychogenic disease disable ; 10 ) Persons unlikely participate study ( infirm ) investigator 's opinion ; 11 ) Have donate blood experience blood collection trial within 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>28 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>